Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,318 total articles
Wearable Devices Ltd. announced Mudra Pro, a next-generation neural sensing wearable platform integrating EMG, PPG, and IMU sensors to enhance AI, extended reality (XR), and human-machine interactions. The device features a thinner ergonomic design, low-latency BLE communication, and supports rapid prototyping and development via the Mudra Studio p…
Chemed Corporation announced it will present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026. The presentation will be webcast live and available for replay. Chemed operates two subsidiaries: VITAS Healthcare, a leader in hospice care, and Roto-Rooter, a provider of plumbing services.
Biofrontera Inc., a U.S.-based biopharmaceutical company specializing in photodynamic therapy for dermatological conditions, announced the return of its social media-driven 'Hats On Campaign' (May 18–24, 2026) to raise awareness of actinic keratosis (AK), a common skin condition caused by sun exposure that can progress to skin cancer if untreated. …
Sprout Social announced the release of its AI-powered social intelligence platform featuring an expanded proprietary AI engine, Trellis. The platform integrates Trellis across its ecosystem to convert social media data into real-time actionable insights, aiding product development, customer care, and overall business strategy. The new Trellis Studi…
Janet Drysdale, Executive VP and Chief Commercial Officer of CN, is scheduled to speak at the 19th Annual Wolfe Research Global Transportation & Industrials Conference on May 21, 2026. The presentation will be webcast live and available for replay, highlighting CN's role in North American rail transportation.
IBEX Limited, a leader in outsourced business services and AI-driven customer experience solutions, announced that its Board of Directors has authorized a $20 million share repurchase program to be executed over the next 12 months. The program aims to deploy capital efficiently while maintaining an aggressive investment strategy in business growth.…
The Oncology Institute, Inc., a leading value-based oncology group in the U.S., announced participation of its CEO and CFO at the upcoming B. Riley Securities Institutional Investor Conference. They will present and hold a fireside chat to discuss the company's operations and growth strategies, accessible via webcast.
Blink Charging reported significant progress in expanding its DC fast charging network, with 136 new fast charging stalls approved or under construction as of March 31, 2026. The company continues to focus on its DC fast charging owner-operator business model, highlighted by high-powered new installations across several states. With a debt-free bal…
ParaZero Technologies Ltd., a Nasdaq-listed aerospace defense company, successfully demonstrated its DefendAir counter-UAS platform at the Black Sea Defense, Aerospace and Security exhibition in Romania. The live simulation involved collaboration with local reseller New Akord Security and showcased integration with multiple defense technologies. At…
Anteris Technologies Global Corp. announced the appointment of Susan Knight and Stephen Denaro to its Board of Directors to enhance governance and strategic capabilities. These appointments come as the company advances its DurAVR® Transcatheter Heart Valve global pivotal trial, preparing for U.S. and European licensure. Knight brings broad audit an…
NewtekOne, Inc., a financial holding company offering a range of business and financial solutions, announced participation and presentations at three investor conferences in May 2026. The company will engage with investors through presentations and one-on-one meetings to highlight its diverse services including banking, lending, electronic payment …
Fate Therapeutics reported Q1 2026 financial results and business updates, highlighting the planned initiation of the Phase 2 RECLAIM-LN trial of FT819 in lupus nephritis patients in H2 2026. The FDA selected FT819 into the CDRP program to accelerate development, and the company presented positive clinical and preclinical data for FT819 and FT839 a…
NEXGEL, Inc. announced the appointment of Dave Hazard as Vice President of Sales for its newly formed BIONX Surgical division. The move supports the commercialization efforts following a transformative acquisition aimed at significantly scaling revenue. Hazard brings extensive experience in orthopedics, spine, and biologics sales leadership, positi…
SRx Health Solutions has invested more than 10% of its investable capital in Astro Investment XVII, an affiliate of Astro Capital that holds investments in SpaceX and other AI and space-related companies. This move aligns the company with high-growth technology sectors and follows its merger agreement with EMJ Crypto Technologies, aiming to leverag…
Intelligent Bio Solutions Inc. announced a significant 46% year-over-year revenue increase to $1.06 million for fiscal third quarter 2026, driven by a 59% rise in cartridge sales which now constitute 66% of quarterly revenue. The company also reported improved gross profit margins exceeding 50%, enhanced operational efficiencies through new manufac…
Vor Bio reported financial results for Q1 2026 with $491.5 million in cash to fund operations into early 2029, ongoing global Phase 3 trials for telitacicept in generalized myasthenia gravis and primary Sjögren's disease, and anticipates topline data in H1 2027. The company highlights the potential of telitacicept to become a foundational therapy i…
Lite Strategy, Inc. reported its fiscal 2026 third quarter results, highlighting successful execution of its covered call option program that generated $0.7 million in net proceeds and deployment of these proceeds plus Litecoin tokens to repurchase over 1.6 million shares. The company emphasized the recent SEC guidance classifying Litecoin (LTC) as…
Bicara Therapeutics granted inducement stock options to newly appointed Chief Commercial Officer, Christopher Sarchi, under its 2026 Inducement Plan to encourage his employment. The options comprise 282,240 shares at the closing Nasdaq price on May 8, 2026, and vest over four years. Bicara focuses on developing bifunctional therapies targeting soli…
Aware, Inc. announced that its Intelligent Liveness biometric solution underwent an independent evaluation by BixeLab, aligned with the CEN/TS 18099 technical specification. The system faced 900 test scenarios including 600 injection attack attempts and 300 bona fide transactions, with zero successful bypasses and zero errors, demonstrating strong …
Brunswick Corporation published its 2025 Sustainability Report, showcasing substantial progress in environmental initiatives, product development, and employee safety. The company exceeded its renewable electricity goals, significantly reduced greenhouse gas emissions, introduced over 100 new products, and maintained favorable employee safety metri…
Bath & Body Works, Inc. is set to release its Q1 2026 financial results on May 27, 2026, before market open. The company will hold a conference call with its CEO and CFO to discuss the results and provide a business update. Supplemental materials and webcast will be available through the company's investor relations website.
SS Innovations International, Inc. reported a significant increase in Q1 2026 revenue to $11.1 million, up 116.8% from Q1 2025, driven by strong growth in installations and surgeries of its SSi Mantra surgical robotic system. Gross margin expanded substantially to 48%, and net loss narrowed compared to the prior year period. Key achievements includ…
EpicQuest Education Group International Limited, trading as EEIQ on Nasdaq, highlights milestones including the first year of profitability at Davis University, significant growth in international student enrollment, and strategic collaborations expanding their global higher education footprint. The company focuses on innovative international progr…
Astrotech Corporation reported its third-quarter fiscal year 2026 financial results with declining R&D expenses as it moves from development to commercialization. The company deployed its TRACER 1000 system across multiple countries and maintains a healthy sales pipeline amid disciplined cost control and strategic investments. Revenue declined comp…
Candel Therapeutics, a clinical-stage biopharmaceutical company developing multimodal immunotherapies for cancer, announced that its CEO, Paul Peter Tak, will present at the Stifel 2026 Virtual Targeted Oncology Forum and the 2026 Jefferies Global Healthcare Conference. The company highlighted progress in its lead product candidates, including agla…
